Results 61 to 70 of about 12,140,521 (311)

Smoking cessation drugs in France: First effects of reimbursement under the general regime

open access: yesTobacco Prevention and Cessation, 2019
Introduction Article 14 of the FCTC recommends facilitating access to smoking cessation medication. Until 2018, some EU countries had specific free of charge program for NRT, but no country had proposed general reimbursement of smoking cessation drugs as
Bertrand Dautzenberg   +1 more
doaj   +1 more source

Using your health insurance. Marshallese

open access: yes, 2019
Title from PDF caption (viewed on December 21, 2021)."440-5079m (9/19/COM)."From program website: "The Compact of Free Association (COFA) Premium Assistance Program provides free health insurance for low-income citizens of the Republic of Marshall ...

core  

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang   +6 more
wiley   +1 more source

The effect of health insurance reimbursement rates on middle-aged and elderly people’s hospital choices: evidence from China

open access: yesHealth Economics Review
Background Adjusting the health insurance reimbursement rate is essential to optimize the allocation of medical resources. This paper investigates the effect of health insurance reimbursement rates on middle-aged and elderly people’s choice of hospitals ...
Biao Li, Xiang Liang, Xiulin Qi
doaj   +1 more source

Should the poor have no medicines to cure? A study on the association between social class and social security among the rural migrant workers in urban China

open access: yesInternational Journal for Equity in Health, 2017
Background The rampant urbanization and medical marketization in China have resulted in increased vulnerabilities to health and socioeconomic disparities among the rural migrant workers in urban China.
Ming Guan
doaj   +1 more source

How health insurance affects the delivery of health care in developing countries [PDF]

open access: yes
Financial crisis is a common state of affairs in the government health sector of many developing countries, and an increasing number are considering implementing user charges and insurance programs to shift some of the financial burden for health ...
Barnum, Howard, Kutzin, Joseph
core  

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić   +4 more
wiley   +1 more source

Availability and reimbursement of biological products for severe asthma in Bulgaria

open access: yesSAGE Open Medicine, 2020
Objectives: This study aims to analyze the reimbursement and cost of biological therapy for severe asthma in Bulgaria during 2014–2019 from the perspective of the National Health Insurance Fund.
Petya Milushewa   +2 more
doaj   +1 more source

The Value of Fixed-Reimbursement Healthcare Insurance- Evidence from Cancer Patients in Ontario, Canada [PDF]

open access: yes
Critical illness insurance (CII) is a fixed-reimbursement scheme conditioned on the event of a loss, not the size of the loss. We investigate demand for CII. Consumers will be willing to purchase CII depending on their degree of risk aversion to the cost
Christopher Longo, Michel Grignon
core  

Do Pharmaceutical Prices Respond to Insurance? [PDF]

open access: yes
Despite the importance of patient insurance in the market for prescription pharmaceuticals, little is known about the impact of insurance on the pricing behavior of pharmaceutical firms.
Nina Pavcnik
core  

Home - About - Disclaimer - Privacy